Heart and Stroke Foundation of Canada/AstraZeneca Research Fellowship - Suuronen


Dr. Erik Suuronen
Ottawa Heart Institute 

Dr. Erik Suuronen is on the cutting edge of a revolutionary new treatment for the blocked coronary arteries that cause heart attacks. You could call it ‘growing your own bypass.’
 
Dr. Suuronen is developing an experimental treatment called ‘therapeutic angiogenesis.’ This approach mimics the natural process of blood vessel formation that occurs during growth and development of the fetus. He takes a patient’s own cells from the blood or bone marrow and turns them into ‘super cells’ in the laboratory. This tissue is then embedded in a polymer matrix and returned to the patient. The activated cells may then grow new blood vessels.
 
This research may lead to new therapies for coronary artery disease. Dr. Suuronen hopes his research will lead to a non-mechanical treatment using only a few cells harvested from a simple blood test to repair damaged arteries around the heart.
 
Dr. Suuronen is networking with scientists, clinicians, and industry in the United Kingdom, the United States, and France in this multidisciplinary research.
 
He will carry out his research at the Ottawa Heart Institute under the supervision of Dr. Marc Ruel. The Heart and Stroke Foundation of Canada and AstraZeneca Inc. are proud to support young investigators like Dr. Suuronen.
 
Supported by AstraZeneca Canada Inc.

 

English